BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17418417)

  • 1. Epi-allelic Erk1 and Erk2 knockdown series for quantitative analysis of T cell Erk regulation and IL-2 production.
    Wille L; Kemp ML; Sandy P; Lewis CL; Lauffenburger DA
    Mol Immunol; 2007 May; 44(12):3085-91. PubMed ID: 17418417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of isoform specific ERK signaling on the effects of interleukin-1β on COX-2 expression and PGE2 production in human chondrocytes.
    Wang X; Li F; Fan C; Wang C; Ruan H
    Biochem Biophys Res Commun; 2010 Nov; 402(1):23-9. PubMed ID: 20883667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes.
    Wang X; Li F; Fan C; Wang C; Ruan H
    Int J Mol Med; 2011 Apr; 27(4):583-9. PubMed ID: 21305249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1.
    Buscà R; Christen R; Lovern M; Clifford AM; Yue JX; Goss GG; Pouysségur J; Lenormand P
    BMC Evol Biol; 2015 Sep; 15():179. PubMed ID: 26336084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2.
    Mehdizadeh A; Somi MH; Darabi M; Farajnia S; Akbarzadeh A; Montazersaheb S; Yousefi M; Bonyadi M
    Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1612-1619. PubMed ID: 28058860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both ERK1 and ERK2 are required for enterovirus 71 (EV71) efficient replication.
    Zhu M; Duan H; Gao M; Zhang H; Peng Y
    Viruses; 2015 Mar; 7(3):1344-56. PubMed ID: 25803100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation.
    Wei F; Xie Y; Tao L; Tang D
    Cell Signal; 2010 Nov; 22(11):1783-9. PubMed ID: 20637859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of phospholipase D2 in increasing interleukin-2 production by T-lymphocytes through activation of mitogen-activated protein kinases ERK1/ERK2.
    Hamdi SM; Cariven C; Coronas S; Malet N; Chap H; Perret B; Salles JP; Record M
    Biochim Biophys Acta; 2008 May; 1781(5):263-9. PubMed ID: 18423386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
    Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
    Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
    Bessard A; Frémin C; Ezan F; Fautrel A; Gailhouste L; Baffet G
    Oncogene; 2008 Sep; 27(40):5315-25. PubMed ID: 18521085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
    Li J; Johnson SE
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1425-33. PubMed ID: 16729973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin activates ERK via EGF receptor in human renal epithelial cells.
    Reich H; Tritchler D; Herzenberg AM; Kassiri Z; Zhou X; Gao W; Scholey JW
    J Am Soc Nephrol; 2005 May; 16(5):1266-78. PubMed ID: 15829704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Redundancy of ERK1 and ERK2 MAP Kinases during Development.
    Frémin C; Saba-El-Leil MK; Lévesque K; Ang SL; Meloche S
    Cell Rep; 2015 Aug; 12(6):913-21. PubMed ID: 26235619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation.
    Voisin L; Saba-El-Leil MK; Julien C; Frémin C; Meloche S
    Mol Cell Biol; 2010 Jun; 30(12):2918-32. PubMed ID: 20368360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raf-independent, PP2A-dependent MEK activation in response to ERK silencing.
    Bae D; Ceryak S
    Biochem Biophys Res Commun; 2009 Aug; 385(4):523-7. PubMed ID: 19465001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total ERK1/2 activity regulates cell proliferation.
    Lefloch R; Pouysségur J; Lenormand P
    Cell Cycle; 2009 Mar; 8(5):705-11. PubMed ID: 19242111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular signal-regulated kinases in T cells. Anti-CD3 and 4 beta-phorbol 12-myristate 13-acetate-induced phosphorylation and activation.
    Whitehurst CE; Boulton TG; Cobb MH; Geppert TD
    J Immunol; 1992 May; 148(10):3230-7. PubMed ID: 1533654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels.
    Lefloch R; Pouysségur J; Lenormand P
    Mol Cell Biol; 2008 Jan; 28(1):511-27. PubMed ID: 17967895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.